Venture capital poured a record $19.8 billion into defense tech in Q1 2026, yet public defense stocks have cratered 12% since the conflict began. The gap between private hype and public reality has never been wider.
When U.S. strikes on Iran began escalating in March, a certain kind of investor saw a straightforward trade. War means weapons. Weapons mean defense contracts. Defense contracts mean stock appreciation. It's an 80-year pattern. This time it didn't work.
The iShares U.S. Aerospace and Defense ETF has dropped roughly 12% since the conflict began, even as the S&P 500 gained 3.5% over the same stretch, according to CNBC's analysis of the period. Northrop Grumman is down more than 30%. L3Harris has fallen over 20%. Lockheed Martin off nearly 13%. Energy stocks, not defense primes, turned out to be the war's clear market winner, breaking a pattern that had held since World War II.
The explanation from analysts is blunt: the war simply isn't big enough yet to move the needle. Sameer Samana, senior global market strategist at Wells Fargo Investment Institute, put it plainly: the conflict would need to last longer or expand materially before earnings estimates for the major primes move higher. Expectations for 2026 earnings growth across General Dynamics, Lockheed, Northrop, L3Harris, and RTX had already slipped to around 12% by end of March, down from 15% at the start of the year. Investors who piled in anticipating a windfall were mostly unwinding positions built on a story that the fundamentals hadn't yet confirmed.
While public defense stocks have been bleeding, private defense tech startups have been raising at a pace that would strike most sober investors as aggressive. VCs deployed that record $19.8 billion in Q1 2026 alone, up from roughly $17 billion a year prior and a universe away from the $5.7 billion deployed in Q1 2024, per PitchBook data. The money is concentrating in a small group of what the industry now calls "neo-primes": Anduril closed a $5 billion Series H in May at a $61 billion valuation, up from $30.5 billion less than a year earlier. Shield AI raised $1.5 billion at $12.7 billion, a 140% jump from its prior round. Saronic, the autonomous shipbuilder, pulled in $1.75 billion at $9.25 billion. Together those three rounds account for nearly $8.75 billion of the year's total haul.
The investor base has changed too. These aren't only specialized defense venture funds anymore. Advent International and JPMorgan Chase's Security and Resiliency Initiative led Shield AI's Series G. Kleiner Perkins led Saronic's round. Andreessen Horowitz and Thrive Capital anchored Anduril's. Institutional money with massive LP bases and longer time horizons has moved in, which raises the stakes for any eventual reckoning.
Here's the thing: early-stage defense startups are now fetching multiples of 17 to 50 times revenue, sometimes higher. At the Fortune Brainstorm Tech conference in June, Anduril CEO Brian Schimpf was asked directly whether the sector is in a bubble. His answer was a nuanced but decisive yes. When the founder of the sector's most celebrated company volunteers that assessment, it's worth taking seriously.
What founders raising right now need to understand
The divergence between private and public markets tells a specific story about narrative versus fundamentals, and it's one that matters for anyone pitching a defense tech round today. Public markets are pricing the Iran conflict on what it has actually done to procurement cycles and near-term earnings. Private markets are pricing a thesis about where military technology is headed over the next decade, which may well be correct. But those are two different bets, and right now they're being made at the same time, in the same sector, under the same geopolitical headline.
The structural headwinds for defense hardware startups don't disappear because the funding environment is hot. Customer concentration is severe: almost everything flows through the Department of Defense. Sales cycles are long. Contracting mechanisms cap upside. Hardware margins are thin and CapEx to commercialization is heavy. Foreign sales face regulatory walls. PitchBook's analysts have called this the sector's "awkward teenage years," and that's probably right. The category is real. The technology is real. The valuations may not be.
Investors who expected a war to hand them immediate returns learned something most experienced defense analysts already knew: conflict accelerates multi-year procurement programs, it doesn't compress them into a quarter. That's a decade-long thesis, and if you bought the ETF in February expecting a short-term pop, you were trading the wrong instrument on the wrong timeline.
The money flowing into Anduril and Saronic and Shield AI makes sense as a long-term bet. What's harder to defend is the assumption that a geopolitical event is a shortcut past the work of actually building a business. Narrative and fundamentals move on different clocks. Right now the clocks are badly out of sync, and the public markets are the ones telling you the time.
Also read: Oil at $100 and a hawkish Fed just rewrote the math for every startup betting on cheap capital • Alphabet posted its biggest revenue quarter ever and Wall Street erased $255 billion in market cap anyway • Blackstone, KKR and Brookfield just paid $7.85 billion upfront for nearly half of Kuwait's oil pipeline backbone
